Literature DB >> 18321971

Influenza A virus neuraminidase limits viral superinfection.

I-Chueh Huang1, Wenhui Li, Jianhua Sui, Wayne Marasco, Hyeryun Choe, Michael Farzan.   

Abstract

Enveloped viruses use multiple mechanisms to inhibit infection of a target cell by more than one virion. These mechanisms may be of particular importance for the evolution of segmented viruses, because superinfection exclusion may limit the frequency of reassortment of viral genes. Here, we show that cellular expression of influenza A virus neuraminidase (NA), but not hemagglutinin (HA) or the M2 proton pump, inhibits entry of HA-pseudotyped retroviruses. Cells infected with H1N1 or H3N2 influenza A virus were similarly refractory to HA-mediated infection and to superinfection with a second influenza A virus. Both HA-mediated entry and viral superinfection were rescued by the neuraminidase inhibitors oseltamivir carboxylate and zanamivir. These inhibitors also prevented the removal of alpha-2,3- and alpha-2,6-linked sialic acid observed in cells expressing NA or infected with influenza A viruses. Our data indicate that NA alone among viral proteins limits influenza A virus superinfection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321971      PMCID: PMC2346733          DOI: 10.1128/JVI.00079-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Plaque formation with influenza viruses in dog kidney cells.

Authors:  P P Ho; A L Young; M Truehaft
Journal:  J Gen Virol       Date:  1976-10       Impact factor: 3.891

2.  Functional significance of sialidose during influenza virus multiplication.

Authors:  J T Seto; R Rott
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

3.  Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium.

Authors:  Mikhail N Matrosovich; Tatyana Y Matrosovich; Thomas Gray; Noel A Roberts; Hans-Dieter Klenk
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 4.  The evolution of epidemic influenza.

Authors:  Martha I Nelson; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2007-01-30       Impact factor: 53.242

Review 5.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

6.  Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

Authors:  M Louise Herlocher; Rachel Truscon; Stephanie Elias; Hui-Ling Yen; Noel A Roberts; Suzanne E Ohmit; Arnold S Monto
Journal:  J Infect Dis       Date:  2004-09-28       Impact factor: 5.226

7.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

8.  Inhibition of virus release by antibodies to surface antigens of influenza viruses.

Authors:  W R Dowdle; J C Downie; W G Laver
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

9.  Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.

Authors:  Michael J Moore; Tatyana Dorfman; Wenhui Li; Swee Kee Wong; Yanhan Li; Jens H Kuhn; James Coderre; Natalya Vasilieva; Zhongchao Han; Thomas C Greenough; Michael Farzan; Hyeryun Choe
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Laboratory characteristics of an attenuated influenza type A (H3N2) virus ('Alice' strain).

Authors:  M Lobmann; A Delem; J Peetermans; C Huygelen
Journal:  J Hyg (Lond)       Date:  1976-10
View more
  70 in total

1.  The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring.

Authors:  S Hossein Fatemi; Timothy D Folsom; Robert J Rooney; Susumu Mori; Tess E Kornfield; Teri J Reutiman; Rachel E Kneeland; Stephanie B Liesch; Kegang Hua; John Hsu; Divyen H Patel
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

2.  Inhibition of superinfection and the evolution of viral latency.

Authors:  Thomas W Berngruber; Franz J Weissing; Sylvain Gandon
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

3.  Budding capability of the influenza virus neuraminidase can be modulated by tetherin.

Authors:  Mark A Yondola; Fiona Fernandes; Alan Belicha-Villanueva; Melissa Uccelini; Qinshan Gao; Carol Carter; Peter Palese
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

4.  Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.

Authors:  Wan-Lin Wu; Christopher Robert Grotefend; Ming-Ting Tsai; Yi-Ling Wang; Vladimir Radic; Hyungjin Eoh; I-Chueh Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

5.  Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.

Authors:  Frank S Heldt; Timo Frensing; Udo Reichl
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 6.  The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Authors:  Brian C DeHaven; Kushol Gupta; Stuart N Isaacs
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

7.  The Multiplicity of Cellular Infection Changes Depending on the Route of Cell Infection in a Plant Virus.

Authors:  Serafín Gutiérrez; Elodie Pirolles; Michel Yvon; Volker Baecker; Yannis Michalakis; Stéphane Blanc
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

8.  Influenza A Virus Reassortment Is Limited by Anatomical Compartmentalization following Coinfection via Distinct Routes.

Authors:  Mathilde Richard; Sander Herfst; Hui Tao; Nathan T Jacobs; Anice C Lowen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

9.  How sticky should a virus be? The impact of virus binding and release on transmission fitness using influenza as an example.

Authors:  Andreas Handel; Victoria Akin; Sergei S Pilyugin; Veronika Zarnitsyna; Rustom Antia
Journal:  J R Soc Interface       Date:  2014-01-15       Impact factor: 4.118

10.  Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).

Authors:  Bin Su; Sébastien Wurtzer; Marie-Anne Rameix-Welti; Dominic Dwyer; Sylvie van der Werf; Nadia Naffakh; François Clavel; Béatrice Labrosse
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.